Cartilage tumor diagnosis and treatment study
Part of Cancer clinical trials.
This study is looking at different types of cartilage tumors to find better ways to diagnose and treat them. If you have a confirmed cartilage tumor, you may be able to join and help researchers learn more about your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cartilage tumor from a biopsy.
- Your tumor is one of these types: enchondroma, atypical cartilage tumor, low-grade or high-grade chondrosarcoma, or a rare type.
- You are being treated or followed at the orthopaedic department of St. Anne's University Hospital in Brno, Czech Republic.
- Your tissue sample is good enough for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a simple blood test (liquid biopsy) can help monitor chondrosarcoma, a type of cartilage cancer. It may offer a less invasive way to track the disease.
This trial studies why people with chondrosarcoma choose to join or not join clinical trials. It collects information through regular electronic reports to improve future cancer research.
This study looks at how well certain types of knee cartilage repair work, using clinical check-ins and imaging (scans). You may be able to help researchers understand which method restores knee surface cartilage best.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This trial studies people with chordoma (a rare bone/soft-tissue tumor) and collects information and samples to learn more about the disease. It may help by improving understanding of chordoma and supporting future research.
This trial is a registry that collects health and medical history from people with osteosarcoma and related bone cancers. It may help researchers learn how these cancers behave and support better future studies.
Hear when a new Chondrosarcomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.